{
    "clinical_study": {
        "@rank": "104344", 
        "arm_group": [
            {
                "arm_group_label": "Treatment A", 
                "arm_group_type": "Other", 
                "description": "No Investigational Product"
            }, 
            {
                "arm_group_label": "Treatment B", 
                "arm_group_type": "Experimental", 
                "description": "Single SC dose of low-dose denosumab"
            }, 
            {
                "arm_group_label": "Treatment C", 
                "arm_group_type": "Experimental", 
                "description": "Single SC dose of high-dose denosumab"
            }
        ], 
        "brief_summary": {
            "textblock": "This study plans to enroll 72 healthy female volunteers. Subjects will be randomized into 1\n      of 3 treatment arms.  The impact of the Investigational Prodcuct on relevant cellular\n      biomarkers in the human breast will be evaluated."
        }, 
        "brief_title": "Effect of Amgen Investigational Product on Cellular Biomarkers in the Human Breast", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy Volunteer, Female, Breast", 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA:\n\n          -  Willing to use, in combination with her partner, 2 non-hormonal methods of effective\n             contraception or practice sexual abstinence. Subjects who are surgically sterile (eg,\n             history of hysterectomy) or whose sexual partner is sterile (eg, history of\n             vasectomy) are not required to use contraceptive measures\n\n          -  Laboratory tests are within clinically acceptable range\n\n          -  Clinically acceptable physical exam and no history or evidence of any clinically\n             significant medical disorder that would pose a risk to subject safety or interfere\n             with study evaluations or procedures.\n\n        EXCLUSION CRITERIA:\n\n          -  Female subject with a prior history of breast cancer; Breast implant in the breast to\n             be biopsied; Known history of fibrocystic breast disease\n\n          -  Subject is unable or unwilling to provide breast biopsy tissue from the upper outer\n             quadrant of her breast\n\n          -  Pregnant or plans to become pregnant while exposed to investigational product\n\n          -  Lactating/breastfeeding or plans to breastfeed while exposed to investigational\n             product\n\n          -  Recent use of any non-approved medications or devices\n\n          -  Uncontrolled thyroid disorder\n\n          -  Significant dental/oral disease\n\n          -  Planned invasive dental procedures\n\n          -  Positive urine screen for alcohol and/or drugs"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02099461", 
            "org_study_id": "20130349"
        }, 
        "intervention": [
            {
                "arm_group_label": "Treatment A", 
                "description": "No investigational product will be administered", 
                "intervention_name": "No treatment", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Treatment B", 
                "description": "Single SC dose", 
                "intervention_name": "Denosumab - low dose", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Treatment C", 
                "description": "Single SC dose", 
                "intervention_name": "Denosumab - high dose", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 29, 2014", 
        "link": {
            "description": "AmgenTrials clinical trials website", 
            "url": "http://www.amgentrials.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Cypress", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90630"
                    }, 
                    "name": "West Coast Clinical Trials"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cypress", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90630"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hollywood", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33024"
                    }, 
                    "name": "Broward Research Group"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hollywood", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33024"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "MRA Clinical Research"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized, Stratified, Open-label, No-treatment-controlled, Parallel Group, Multicenter Phase 1 Trial to Evaluate the Effect of Denosumab on Cellular Proliferation in the Human Breast", 
        "overall_contact": {
            "last_name": "Amgen Call Center", 
            "phone": "866-572-6436"
        }, 
        "overall_official": {
            "affiliation": "Amgen", 
            "last_name": "MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Ratio of post-baseline to baseline Ki-67 index", 
            "measure": "Ratio of post-baseline to baseline Ki-67 index", 
            "safety_issue": "No", 
            "time_frame": "Approximately 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02099461"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Amgen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Amgen", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}